Effects of Constraints Induced Movement Therapy Versus Mirror Therapy in Children With Hemiplegic Cerebral Palsy

March 31, 2023 updated by: Riphah International University

Effects of Constraints Induced Movement Therapy Versus Mirror Therapy on Hand Dexterity and Grip Strength in Children With Hemiplegic Cerebral Palsy

The aim of this study is to find Effects of constraints induced movement therapy (CIMT) versus mirror therapy (MT) on hand dexterity and grip strength in children with hemiplegic cerebral palsy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Although quite number of research has been done on effects of CIMT and mirror therapy but most of the studies included stroke population. There was no literature on comparative effect of both CIMT and Mirror therapy in children with hemiplegic cerebral palsy. This study will be covering specifically cerebral palsy children to have better treatment techniques to be introduced in therapeutic programs of hemiplegic cerebral palsy children.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Mobility Quest

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children of age range 9-14 year
  • Children with diagnosed hemiplegic cerebral palsy
  • Children who can perform active extension of affected wrist and more than
  • two fingers at an angle of more than 10 degrees
  • Active abduction of affected thumb at an angle of 10 degrees
  • Children who can respond to simple communication-

Exclusion Criteria:

  • Children with uncontrolled seizures
  • Botulinum toxin injections or orthopedic surgery in the upper or lower
  • extremities within the previous 12 months or planned within the study period
  • Children with depression who were unable to cooperate in treatment
  • Children who are unable to perform active task training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Group
Mirror Therapy
Other: Mirror Therapy (MT)
I will apply Mirror Therapy on effected hand to obeserve the hand dexterity and grip strength
Experimental: Treatment Group
Constraint Induced Movement Therapy
Other: Constraint Induced Movement Therapy (CIMT)
I will apply CIMT on effected hand to observe the hand dexterity and grip strength
Other Names:
  • CIMT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
9 Hole pegboard test:
Time Frame: 3 months
The 9 hole peg test is a standardized quantitative assessment used to measure finger dexterity in patients with various neurological diagnosis.
3 months
Haptic (Tactile) Recognition Test:
Time Frame: 3 months
it's a quantitative measure of haptic (tactile) object recognition design to test one's ability to recognize everyday objects across seven sensory attributes using 14 sets of objects. Haptic recognition of everyday objects is quite fast and highly accurate with 96% correctly named: 68% in less than 3 s and 94% within 5 sec.
3 months
Hand Dynamometer:
Time Frame: 3 months
Hand Dynamometer: Hand dynamometer is an evaluation tool that is used to measure isometric grip force. . Once the grip position is adjusted, the user holds the handle and squeezes the handle
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Shabana Ashraf, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2022

Primary Completion (Actual)

February 15, 2023

Study Completion (Actual)

February 15, 2023

Study Registration Dates

First Submitted

December 13, 2022

First Submitted That Met QC Criteria

December 13, 2022

First Posted (Actual)

December 21, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2023

Last Update Submitted That Met QC Criteria

March 31, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR&AHS/22/0730

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Constraint Induced Movement Therapy (CIMT)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe